Gonorrhea diagnostics: Key market research findings
- Growing use of molecular diagnostics
- The Americas to lead the market geographically
- Key vendors are Abbott Laboratories, Beckman Coulter, Roche Diagnostics, and Siemens
Technavio’s market research analysts predict the global gonorrhea diagnostics market to grow at a CAGR of more than 9% between 2016 and 2020. Vendors are introducing several diagnostics in the healthcare infrastructure for testing services which has led to faster and precise testing results, enabling better gonorrhoea treatment. Growing public awareness and a rise in disposable income have increased the demand for gonorrhea diagnostics in several emerging markets. Also, governments of these countries are funding small- and medium-sized companies to build healthcare infrastructure, increase healthcare budgets, and come up with technologically advanced products. The improvement in the healthcare infrastructure will increase the demand for gonorrhea treatment and the patient base, especially in rural areas. The Americas will dominate the market during the forecast period and is likely to occupy more than 49% of the total market share. Factors such as growing laboratory automation, shift to molecular diagnostic tests, and increasing FDA approvals for new products will drive the market in this region.
The new industry research report from Technavio discusses in detail the key drivers and trends responsible for the growth of this market and its sub-segments.
“Physicians are increasingly using molecular diagnostics to study the chemical structure of DNA to determine the presence of an abnormal gene sequences, which could be the potential cause for the disease. Molecular diagnostics provides the first step toward understanding a disease at the molecular level and is the fastest-growing clinical diagnostics technology. Some of the latest technologies in molecular diagnostics include PCR-based techniques, nucleic acid amplification tests, and DNA nanotechnology,” says Barath Palada, Lead Analyst, Healthcare & Lifesciences, Technavio Research
The molecular diagnostics procedure involves the nucleic acid extraction mixtures from gonorrhea cultures that act as a template for the diagnosis. The advancement in molecular biology has played a crucial role in the molecular diagnostics technology positively and has helped in developing a rapid and safe assays for diseases like gonorrhea. Nucleic acid amplification test is the most important molecular diagnostic test involved in the gonorrhea diagnosis.
This market is highly fragmented and competitive, with the presence of well-diversified international, regional, and local vendors. Local vendors face stiff competition in the market as the international players are increasing their footprints, especially in terms of features and quality. The competition in this market is expected to intensify during the forecast period with an increase in product extensions and technological innovations and an increase in mergers and acquisitions. The lack of skilled laboratory professionals and requirement for high capital investment are major challenges for regional and local players, preventing them from expanding dynamically.
A more detailed analysis is available in the Technavio report, Global Gonorrhea Diagnostics Market 2016-2020.
We can customize reports by other regions and specific segments upon request.
Other Related Reports:
Global Sexually Transmitted Disease (STD) Testing Market 2014-2018
